Transcat, Inc. (NASDAQ: TRNS) is a Industrials company (Specialty Business Services) with a market capitalization of $937M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Transcat, Inc. had a Maz Rating of 3.83 out of 5 (B+, Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.27), above most of its sector; its weakest was Valuation (1.13), among the most expensive in its sector. The other factors: Profitability 3.35 (around the middle of its sector); Financial Health 3.23 (around the middle of its sector); Growth 2.78 (around the middle of its sector). The current rating is for members: log in to see it.
At $99.65, Transcat, Inc. trades at 203.5x trailing earnings, 2.6x sales and 3.0x book value, with an EV/EBITDA of 26.5. Over the last twelve months it generated about $363M of revenue and $5M of net income. It runs a gross margin of 32.8%, an operating margin of 3.3% and a net margin of 1.3%. It shows return on equity of 1.5%, return on invested capital of 1.7% and a free cash flow yield of 2.5%. On the balance sheet: a debt-to-equity ratio of 0.49 and a current ratio of 2.57. Over the past 52 weeks the share price ranged from $50.23 to $112.44, with a beta of 0.64.
Transcat, Inc. does not currently pay a dividend.
10 Wall Street analyst ratings cover the stock: 9 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.